Loratadine 5 mg/0.5 mL Topical Gel is a semisolid formulation designed for easy and precise application on the skin through a convenient pump mechanism. This gel-like consistency ensures targeted treatment and effective absorption of the active ingredient, loratadine, directly at the site of application.
This formulation is primarily used to treat allergic skin conditions, providing relief from symptoms such as itching, redness, and inflammation associated with allergic reactions. It is an ideal choice for patients seeking localized treatment for their allergic skin issues.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Loratadine 5 mg/0.5 mL Topical Gel is a semisolid formulation designed for easy and precise application on the skin, allowing for targeted treatment or absorption of active ingredients. This gel-like consistency is dispensed through a pump mechanism, ensuring accurate dosing and minimizing wastage. While loratadine is primarily known as an oral antihistamine used to treat allergic reactions, its topical application can be beneficial for localized allergic skin reactions, such as hives or contact dermatitis. However, it is crucial to consider potential drug interactions when using this formulation, especially for patients who are on multiple medications or have complex medical histories.
Although loratadine is generally considered to have a low potential for drug interactions due to its minimal systemic absorption when applied topically, it is still important to be cautious. Patients using other topical medications should be aware of the possibility of interactions that could alter the efficacy or increase the risk of side effects. For instance, applying multiple topical products simultaneously can affect the absorption rate of loratadine, potentially leading to reduced effectiveness or increased local irritation. It is advisable to space out the application of different topical treatments to avoid such interactions.
For patients who are also taking oral medications, particularly those metabolized by the liver enzyme CYP3A4, there is a theoretical risk of interaction, although this is more relevant for oral loratadine. Medications such as ketoconazole, erythromycin, and cimetidine are known to inhibit CYP3A4 and could potentially increase loratadine levels if significant systemic absorption occurs. However, given the topical route of administration, this risk is considerably lower. Nonetheless, prescribers should remain vigilant and consider the patient's complete medication profile when recommending this formulation.
Patients with pre-existing skin conditions or those using other dermatological treatments should consult with their healthcare provider to ensure compatibility and avoid exacerbating their condition. Additionally, individuals with known hypersensitivity to loratadine or any of the gel's excipients should refrain from using this product to prevent adverse reactions.
In summary, while the risk of drug interactions with Loratadine 5 mg/0.5 mL Topical Gel is relatively low, it is essential for both patients and prescribers to be aware of potential interactions, especially in the context of polypharmacy or concurrent use of other topical agents. If you have any questions or concerns about using this formulation, please reach out to us for further guidance and support.
Loratadine 5 mg/0.5 mL Topical Gel is a specialized formulation designed to deliver the antihistamine loratadine directly to the skin, providing targeted relief from allergic reactions and associated symptoms. This semisolid gel is dispensed through a convenient pump mechanism, allowing for precise dosing and easy application. The gel-like consistency ensures that the active ingredient is evenly distributed across the application site, promoting optimal absorption and efficacy.
When applied topically, loratadine works by blocking the action of histamine, a substance in the body that causes allergic symptoms. Histamine is released by the immune system in response to allergens, leading to symptoms such as itching, redness, and swelling. By inhibiting histamine receptors in the skin, loratadine helps to alleviate these symptoms, providing relief from conditions such as allergic contact dermatitis, urticaria (hives), and other localized allergic reactions.
The topical delivery of loratadine offers several advantages over oral administration, particularly for patients who experience localized allergic reactions. By applying the medication directly to the affected area, the formulation minimizes systemic exposure and potential side effects, while maximizing the concentration of the active ingredient at the site of action. This targeted approach can lead to faster relief and improved patient outcomes.
The gel formulation is designed to be non-greasy and quickly absorbed, ensuring that it does not leave a residue on the skin or clothing. This makes it suitable for use throughout the day, as needed, without interfering with daily activities. The pump mechanism ensures that each dose is consistent, reducing the risk of over- or under-application, and enhancing the overall safety and effectiveness of the treatment.
For prescribers, this formulation offers a versatile option for managing allergic skin conditions, particularly in patients who may not tolerate oral antihistamines or who require localized treatment. It can be used as a standalone therapy or in conjunction with other treatments, depending on the severity and nature of the allergic reaction.
If you have any questions about Loratadine 5 mg/0.5 mL Topical Gel, its use, or its suitability for specific conditions, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide expert guidance and support to both patients and healthcare providers.
Loratadine 5 mg/0.5 mL Topical Gel, dispensed through a convenient pump mechanism, offers a unique approach to delivering antihistamine therapy directly to the skin. While traditionally used for alleviating symptoms associated with allergic reactions such as itching, redness, and swelling, this topical formulation may have additional applications that extend beyond these common uses. The gel's targeted delivery system allows for localized treatment, which can be particularly beneficial in managing conditions where systemic administration of antihistamines might not be ideal or necessary.
One potential use of Loratadine topical gel is in the management of localized allergic dermatitis, where direct application can provide rapid relief at the site of irritation without the need for systemic exposure. This can be especially advantageous for patients who experience side effects from oral antihistamines or for those who require treatment of a specific area without affecting the entire body. Additionally, the gel formulation may be used in conjunction with other therapies for conditions like chronic urticaria, where it can help manage flare-ups by providing immediate relief to affected areas.
Furthermore, the topical application of Loratadine may be explored in the context of insect bites or stings, where its anti-inflammatory properties can help reduce localized swelling and discomfort. This can be particularly useful in outdoor settings or for individuals who are prone to insect-related allergic reactions.
For prescribers, considering Loratadine topical gel as an adjunctive treatment in dermatological conditions characterized by histamine-mediated symptoms could enhance patient outcomes. Its use in combination with other topical agents, such as corticosteroids or emollients, may provide a synergistic effect, improving the overall therapeutic regimen. As always, it is important to evaluate each patient's specific needs and medical history to determine the appropriateness of this formulation.
If you have any questions or require further information about the potential uses of Loratadine 5 mg/0.5 mL Topical Gel, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to assist you with any inquiries or to provide additional guidance on the use of this formulation.
Loratadine 5 mg/0.5 mL Topical Gel is used for targeted treatment or absorption of active ingredients through the skin, often for conditions like allergies or localized skin reactions.
Apply the gel by dispensing it through the pump mechanism onto the affected area of the skin. Use as directed by your healthcare provider for precise application.
It is generally advised not to apply the gel on broken or irritated skin unless directed by a healthcare professional.
The frequency of application should be as prescribed by your healthcare provider, typically based on the severity of your condition and your response to treatment.
Consult with a healthcare provider before using this gel on children, as safety and efficacy may vary based on age and specific health conditions.
If you miss a dose, apply it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not double the dose.
Before using other topical products, consult your healthcare provider to avoid potential interactions or reduced effectiveness of the gel.
Possible side effects may include skin irritation, redness, or itching at the application site. If you experience severe reactions, contact your healthcare provider.
Store the gel at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets.
Consult your healthcare provider before using this gel if you are pregnant or breastfeeding to ensure it is safe for you and your baby.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)